Biological Diagnosis and Monitoring of Chronic Nitrous Oxide Abuse

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14-65
SponsorUniversity Hospital, Lille

About this trial

There is a toxicity linked to the chronic use of nitrous oxide, leading to neurological disorders such as combined sclerosis of the spinal cord. One thus frequently observes patients presenting disorders of walking or paresthesias, of more or less resolving evolution being able to go until the need for using a wheelchair and more recently cases of thrombosis were reported Serum or urine N2O assays are rarely performed routinely, because they do not allow to ensure a real exposure due to the very short half-life of this gas in the body. Thus, other biological monitoring markers are mentioned in the literature, such as vitamin B12 or homocysteine. Unfortunately, there are still no recommendations for biological monitoring of nitrous oxide consumption. Moreover, underlying mechanisms leading to clinical outcomes remains misunderstood.

Eligibility criteria

Qualifiers

A current or former recreational nitrous oxide user defined

With associated clinical signs (group 1)

Without associated clinical signs (group 2)

With or without clinico-biological sequelae associated with use

Disqualifiers

Pregnant or breastfeeding women

Never used nitrous oxide or stopped using it more than 6 months ago

Lack of social security coverage

Not willing to participate in the entire study

Trial design

Treatments tested in this trial

  • blood collection

Treatment groups

356 Participants
are divided into 2 treatment groups

Sponsors and collaborators